Aristides Capital’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,000
Closed -$202K 237
2024
Q4
$202K Buy
+8,000
New +$202K 0.04% 227